BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19484507)

  • 1. Protective effect of copy number polymorphism of glutathione S-transferase T1 gene on melanoma risk in presence of CDKN2A mutations, MC1R variants and host-related phenotypes.
    Chaudru V; Lo MT; Lesueur F; Marian C; Mohamdi H; Laud K; Barrois M; Chompret A; Avril MF; Demenais F; Bressac-de Paillerets B
    Fam Cancer; 2009; 8(4):371-7. PubMed ID: 19484507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of glutathione S-transferases in melanoma susceptibility: association with GSTP1 rs1695 polymorphism.
    Ibarrola-Villava M; Martin-Gonzalez M; Lazaro P; Pizarro A; Lluch A; Ribas G
    Br J Dermatol; 2012 Jun; 166(6):1176-83. PubMed ID: 22251241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
    Demenais F; Mohamdi H; Chaudru V; Goldstein AM; Newton Bishop JA; Bishop DT; Kanetsky PA; Hayward NK; Gillanders E; Elder DE; Avril MF; Azizi E; van Belle P; Bergman W; Bianchi-Scarrà G; Bressac-de Paillerets B; Calista D; Carrera C; Hansson J; Harland M; Hogg D; Höiom V; Holland EA; Ingvar C; Landi MT; Lang JM; Mackie RM; Mann GJ; Ming ME; Njauw CJ; Olsson H; Palmer J; Pastorino L; Puig S; Randerson-Moor J; Stark M; Tsao H; Tucker MA; van der Velden P; Yang XR; Gruis N;
    J Natl Cancer Inst; 2010 Oct; 102(20):1568-83. PubMed ID: 20876876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees.
    Chaudru V; Laud K; Avril MF; Minière A; Chompret A; Bressac-de Paillerets B; Demenais F
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2384-90. PubMed ID: 16214921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.
    Goldstein AM; Landi MT; Tsang S; Fraser MC; Munroe DJ; Tucker MA
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2208-12. PubMed ID: 16172233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma.
    Mössner R; Anders N; König IR; Krüger U; Schmidt D; Berking C; Ziegler A; Brockmöller J; Kaiser R; Volkenandt M; Westphal GA; Reich K
    Arch Dermatol Res; 2007 Jan; 298(8):371-9. PubMed ID: 17072629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
    Fargnoli MC; Gandini S; Peris K; Maisonneuve P; Raimondi S
    Eur J Cancer; 2010 May; 46(8):1413-20. PubMed ID: 20189796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
    Goldstein AM; Chaudru V; Ghiorzo P; Badenas C; Malvehy J; Pastorino L; Laud K; Hulley B; Avril MF; Puig-Butille JA; Miniere A; Marti R; Chompret A; Cuellar F; Kolm I; Mila M; Tucker MA; Demenais F; Bianchi-Scarra G; Puig S; de-Paillerets BB
    Int J Cancer; 2007 Aug; 121(4):825-31. PubMed ID: 17397031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients.
    Ghiorzo P; Bonelli L; Pastorino L; Bruno W; Barile M; Andreotti V; Nasti S; Battistuzzi L; Grosso M; Bianchi-Scarrà G; Queirolo P
    Exp Dermatol; 2012 Sep; 21(9):718-20. PubMed ID: 22804906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers.
    Cuéllar F; Puig S; Kolm I; Puig-Butille J; Zaballos P; Martí-Laborda R; Badenas C; Malvehy J
    Br J Dermatol; 2009 Jan; 160(1):48-53. PubMed ID: 18795926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSTs polymorphisms are associated with epigenetic silencing of CDKN2A gene in esophageal squamous cell carcinoma.
    Forghanifard MM; Aarabi A; Nasiri Aghdam M; Memar B; Hasanzadeh Khayat M; Dadkhah E; Abbaszadegan MR
    Environ Sci Pollut Res Int; 2020 Sep; 27(25):31269-31277. PubMed ID: 32488710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of three important genes in pigmentation and melanoma susceptibility: CDKN2A, MC1R and HERC2/OCA2.
    Ibarrola-Villava M; Fernandez LP; Pita G; Bravo J; Floristan U; Sendagorta E; Feito M; Avilés JA; Martin-Gonzalez M; Lázaro P; Benítez J; Ribas G
    Exp Dermatol; 2010 Sep; 19(9):836-44. PubMed ID: 20629734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GSTM1, GSTP1, and GSTT1 genetic variability in Turkish and worldwide populations.
    Karaca S; Karaca M; Cesuroglu T; Erge S; Polimanti R
    Am J Hum Biol; 2015; 27(3):310-6. PubMed ID: 25515186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular melanoma is not associated with CDKN2A or MC1R variants--a population-based study.
    Vajdic C; Kricker A; Duffy DL; Aitken JF; Stark M; ter Huurne JA; Martin NG; Armstrong BK; Hayward NK
    Melanoma Res; 2003 Aug; 13(4):409-13. PubMed ID: 12883368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of loss of function MC1R variants in genetic susceptibility of familial melanoma in Spain.
    de Torre C; Garcia-Casado Z; Martínez-Escribano JA; Botella-Estrada R; Bañuls J; Oliver V; Mercader P; Azaña JM; Frias J; Nagore E
    Melanoma Res; 2010 Aug; 20(4):342-8. PubMed ID: 20539244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
    Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
    J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.
    Pastorino L; Bonelli L; Ghiorzo P; Queirolo P; Battistuzzi L; Balleari E; Nasti S; Gargiulo S; Gliori S; Savoia P; Abate Osella S; Bernengo MG; Bianchi Scarrà G
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):700-9. PubMed ID: 18983535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families.
    Peric B; Cerkovnik P; Novakovic S; Zgajnar J; Besic N; Hocevar M
    BMC Med Genet; 2008 Sep; 9():86. PubMed ID: 18803811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.